Similar articles

• Severe sulfonylurea-induced hypoglycemia: a problem of uncritical prescription and deficiencies of diabetes care in geriatric patients.

  Holstein A, Hammer C, Hahn M, Kulamadayil NS, Kovacs P. Holstein A, et al. Expert Opin Drug Saf. 2010 Sep;9(5):675-81. doi: 10.1517/14740338.2010.492777. Expert Opin Drug Saf. 2010. PMID: 20553106
• Hypoglycaemia in patients with type 2 diabetes treated with a combination of metformin and sulphonylurea therapy in France.

  Vexiau P, Mavros P, Krishnarajah G, Lyu R, Yin D. Vexiau P, et al. Diabetes Obes Metab. 2008 Jun;10 Suppl 1:16-24. doi: 10.1111/j.1463-1326.2008.00883.x. Diabetes Obes Metab. 2008. PMID: 18435670
• Recurrent sulfonylurea induced nocturnal hypoglycemia managed with tolbutamide.

  Borst GC 3rd. Borst GC 3rd. J Ky Med Assoc. 1988 Mar;86(3):129-30. J Ky Med Assoc. 1988. PMID: 3356924 No abstract available.
• Long-acting sulfonylureas -- long-acting hypoglycaemia.

  Veitch PC, Clifton-Bligh RJ. Veitch PC, et al. Med J Aust. 2004 Jan 19;180(2):84-5. Med J Aust. 2004. PMID: 14723592 Review. No abstract available.
• Anti-diabetic drugs as a cause of hypoglycaemia among acute medical admissions in Hong Kong and Singapore--relationship to the prescribing patterns in diabetic patients.

  Chan TY. Chan TY. Singapore Med J. 1998 Apr;39(4):186-8. Singapore Med J. 1998. PMID: 9676153 Review.